A Phase 1 Dose-Escalation Study of the Cardiac Myosin Inhibitor Aficamten in Healthy Participants

Autor: Malik, Fady I., Robertson, Laura A., Armas, Danielle R., Robbie, Edward P., Osmukhina, Anna, Xu, Donghong, Li, Hanbin, Solomon, Scott D.
Zdroj: In JACC: Basic to Translational Science August 2022 7(8):763-775
Databáze: ScienceDirect